282 related articles for article (PubMed ID: 1365657)
1. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action.
Marek GJ; McDougle CJ; Price LH; Seiden LS
Psychopharmacology (Berl); 1992; 109(1-2):2-11. PubMed ID: 1365657
[TBL] [Abstract][Full Text] [Related]
2. Possible trazodone potentiation of fluoxetine: a case series.
Nierenberg AA; Cole JO; Glass L
J Clin Psychiatry; 1992 Mar; 53(3):83-5. PubMed ID: 1548249
[TBL] [Abstract][Full Text] [Related]
3. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
Schatzberg AF; Dessain E; O'Neil P; Katz DL; Cole JO
J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study of serotonergic antidepressants in treatment of dysthymia.
Rosenthal J; Hemlock C; Hellerstein DJ; Yanowitch P; Kasch K; Schupak C; Samstag L; Winston A
Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):933-41. PubMed ID: 1513932
[TBL] [Abstract][Full Text] [Related]
5. History of antidepressants: successes and failures.
Kelwala S; Stanley M; Gershon S
J Clin Psychiatry; 1983 May; 44(5 Pt 2):40-8. PubMed ID: 6222036
[No Abstract] [Full Text] [Related]
6. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of double depression: a preliminary study with serotonergic antidepressants.
Hellerstein DJ; Yanowitch P; Rosenthal J; Hemlock C; Kasch K; Samstag LW; Winston A
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):139-47. PubMed ID: 8115668
[TBL] [Abstract][Full Text] [Related]
8. Interactions of trazodone with serotonin neurons and receptors.
Fuller RW; Snoddy HD; Cohen ML
Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
Maes M; Vandoolaeghe E; Desnyder R
J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
[TBL] [Abstract][Full Text] [Related]
10. Trazodone increases extracellular serotonin levels in the frontal cortex of rats.
Pazzagli M; Giovannini MG; Pepeu G
Eur J Pharmacol; 1999 Nov; 383(3):249-57. PubMed ID: 10594316
[TBL] [Abstract][Full Text] [Related]
11. A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
Perry PJ; Garvey MJ; Kelly MW; Cook BL; Dunner FJ; Winokur G
J Clin Psychiatry; 1989 Aug; 50(8):290-4. PubMed ID: 2668259
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of serotonin uptake inhibitors in depression.
Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
[TBL] [Abstract][Full Text] [Related]
13. Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats.
Balsara JJ; Jadhav SA; Gaonkar RK; Gaikwad RV; Jadhav JH
Psychopharmacology (Berl); 2005 May; 179(3):597-605. PubMed ID: 15614572
[TBL] [Abstract][Full Text] [Related]
14. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?
Di Rosso ME; Palumbo ML; Genaro AM
Pharmacol Res; 2016 Jul; 109():101-7. PubMed ID: 26644208
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.
Pigott TA; L'Heureux F; Rubenstein CS; Bernstein SE; Hill JL; Murphy DL
J Clin Psychopharmacol; 1992 Jun; 12(3):156-62. PubMed ID: 1629380
[TBL] [Abstract][Full Text] [Related]
17. Obsessive compulsive disorder, depression, and fluoxetine.
Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
[TBL] [Abstract][Full Text] [Related]
18. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
Blier P; de Montigny C
Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353
[TBL] [Abstract][Full Text] [Related]
19. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders.
Kallepalli BR; Bhatara VS; Fogas BS; Tervo RC; Misra LK
J Child Adolesc Psychopharmacol; 1997; 7(2):97-107. PubMed ID: 9334895
[TBL] [Abstract][Full Text] [Related]
20. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
